The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Open accessAbstract
Anemia is prevalent in patients with chronic kidney disease (CKD) and is associated with a lower quality of life and a higher risk of adverse outcomes including cardiovascular disease and death. Anemia management in CKD patients currently revolves around the use of erythropoiesis-stimulating agents (ESAs) and supplemental iron. However, many patients do not respond adequately and/or require high doses of these medications. Furthermore, recent clinical trials have shown that targeting higher hemoglobin levels with conventional therapies leads to increased cardiovascular morbidity and mortality, particularly when higher doses of ESAs are used, and in patients who are poorly responsive to therapy. One explanation for the poor response to conventional therapies in some patients is that these treatments do not fully address the underlying cause of the anemia. In many CKD patients, like patients with other chronic inflammatory diseases, poor absorption of dietary iron and inability to utilize the body's iron stores contributes to the anemia. Recent research suggests that these abnormalities in iron balance may be caused by elevated levels of the key iron regulatory hormone hepcidin. This article reviews the pathogenesis of anemia in CKD, the role and regulation of hepcidin in systemic iron homeostasis and the anemia of CKD, and the potential diagnostic and therapeutic implications of these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“The first described epcidin assay was an immunodot assay to meaure urinary hepcidin.(28,29) However, this assay is emiquantitative, laborious, and not suitable for erum hepcidin measurements.”
MethodHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Research works printed but not linked: 88
- Szczech, 2008, Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes, Kidney Int., 74, 791, 10.1038/ki.2008.295 · DOI · Paper page
- Malyszko, 2007, Hepcidin in anemia and inflammation in chronic kidney disease, Kidney Blood Press Res., 30, 15, 10.1159/000098522 · DOI
- Macdougall, 1996, A randomized controlled study of iron supplementation in patients treated with erythropoietin, Kidney Int., 50, 1694, 10.1038/ki.1996.487 · DOI · Paper page
- Fudin, 1998, Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study, Nephron, 79, 299, 10.1159/000045053 · DOI
- Markowitz, 1997, An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin, Clin Nephrol., 48, 34
- Eleftheriadis, 2007, Disturbances of acquired immunity in hemodialysis patients, Semin Dial., 20, 440, 10.1111/j.1525-139X.2007.00283.x · DOI · Paper page
- Ganz, 2008, Immunoassay for human serum hepcidin, Blood, 112, 4292, 10.1182/blood-2008-02-139915 · DOI · Paper page
- Ashby, 2009, Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease, Kidney Int., 75, 976, 10.1038/ki.2009.21 · DOI · Paper page
- Zaritsky, 2009, Hepcidin—a potential novel biomarker for iron status in chronic kidney disease, Clin J Am Soc Nephrol., 4, 1051, 10.2215/CJN.05931108 · DOI · Paper page
- Ramey, 2009, Hepcidin targets ferroportin for degradation in hepatocytes, Haematologica
- Nicolas, 2002, Severe iron deficiency anemia in transgenic mice expressing liver hepcidin, Proc Natl Acad Sci U S A, 99, 4596, 10.1073/pnas.072632499 · DOI · Paper page
- Nemeth, 2003, Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein, Blood, 101, 2461, 10.1182/blood-2002-10-3235 · DOI · Paper page
- Pietrangelo, 2006, Hereditary hemochromatosis, Biochim Biophys Acta., 1763, 700, 10.1016/j.bbamcr.2006.05.013 · DOI
- Kawabata, 1999, Molecular cloning of transferrin receptor 2, J Biol Chem., 274, 20826, 10.1074/jbc.274.30.20826 · DOI · Paper page
- Bridle, 2003, Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis, Lancet, 361, 669, 10.1016/S0140-6736(03)12602-5 · DOI · Paper page
- Nemeth, 2005, Hepcidin is decreased in TFR2 hemochromatosis, Blood, 105, 1803, 10.1182/blood-2004-08-3042 · DOI · Paper page
- Huang, 2005, A mouse model of juvenile hemochromatosis, J Clin Invest., 115, 2187, 10.1172/JCI25049 · DOI · Paper page
- Niederkofler, 2005, Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload, J Clin Invest., 115, 2180, 10.1172/JCI25683 · DOI · Paper page
- Kawabata, 2005, Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis, Blood, 105, 376, 10.1182/blood-2004-04-1416 · DOI · Paper page
- Muckenthaler, 2003, Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis, Nat Genet., 34, 102, 10.1038/ng1152 · DOI · Paper page
- Wallace, 2005, First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin, Gut, 54, 980, 10.1136/gut.2004.062018 · DOI · Paper page
- Wang, 2005, A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression, Cell Metab., 2, 399, 10.1016/j.cmet.2005.10.010 · DOI · Paper page
- Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X · DOI · Paper page
- Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance, J Clin Invest., 117, 1933, 10.1172/JCI31342 · DOI · Paper page
- Xia, 2008, Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin, Blood, 111, 5195, 10.1182/blood-2007-09-111567 · DOI · Paper page
- Truksa, 2007, Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9, Br J Haematol., 139, 138, 10.1111/j.1365-2141.2007.06728.x · DOI
- Truksa, 2009, Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness, Blood, 113, 688, 10.1182/blood-2008-05-160184 · DOI
- Island, 2009, A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis, Haematologica, 94, 720, 10.3324/haematol.2008.001784 · DOI
- Yu, 2008, Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism, Nat Chem Biol., 4, 33, 10.1038/nchembio.2007.54 · DOI · Paper page
- Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat Genet., 41, 478, 10.1038/ng.320 · DOI · Paper page
- Corradini, 2009, Bone morphogenetic protein signaling is impaired in a Hfe knockout mouse model of hemochromatosis, Gastroenterology, 137, 1489, 10.1053/j.gastro.2009.06.057 · DOI
- Bennett, 2000, Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor, Nature, 403, 46, 10.1038/47417 · DOI · Paper page
- West, 2001, Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites, J Mol Biol., 313, 385, 10.1006/jmbi.2001.5048 · DOI
- Vujić Spasić, 2008, Hfe acts in hepatocytes to prevent hemochromatosis, Cell Metab., 7, 173, 10.1016/j.cmet.2007.11.014 · DOI
- Wallace, 2007, Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload, Gastroenterology, 132, 301, 10.1053/j.gastro.2006.11.028 · DOI
- Pietrangelo, 2005, Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes, Gastroenterology, 128, 470, 10.1053/j.gastro.2004.11.057 · DOI
- Wallace, 2009, Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload, Hepatology, 50, 1992, 10.1002/hep.23198 · DOI · Paper page
- Kautz, 2009, BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression, Blood, 114, 2515, 10.1182/blood-2009-02-206771 · DOI
- Calzolari, 2006, TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway, J Cell Sci., 119, 4486, 10.1242/jcs.03228 · DOI · Paper page
- Ramey, 2009, Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes, Haematologica, 94, 765, 10.3324/haematol.2008.003541 · DOI
- Lee, 2005, Regulation of hepcidin transcription by interleukin-1 and interleukin-6, Proc Natl Acad Sci U S A, 102, 1906, 10.1073/pnas.0409808102 · DOI · Paper page
- Zhang, 2006, Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response, Cell, 124, 587, 10.1016/j.cell.2005.11.040 · DOI · Paper page
- Oliveira, 2009, ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity, PLoS One, 4, e6618, 10.1371/journal.pone.0006618 · DOI
- Liu, 2005, Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages, Blood Cells Mol Dis., 35, 47, 10.1016/j.bcmd.2005.04.006 · DOI · Paper page
- Koening, 2009, Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi, Blood, 114, 1913, 10.1182/blood-2009-03-209577 · DOI
- Kuninger, 2006, Complex biosynthesis of the muscle-enriched iron regulator RGMc, J Cell Sci., 119, 3273, 10.1242/jcs.03074 · DOI
- Zhang, 2007, Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin, J Biol Chem., 282, 12547, 10.1074/jbc.M608788200 · DOI
- Kuninger, 2008, Pro-protein convertases control the maturation and processing of the iron-regulatory protein, RGMc/hemojuvelin, BMC Biochem., 9, 9, 10.1186/1471-2091-9-9 · DOI
- Lin, 2008, Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site, Blood Cells Mol Dis., 40, 122, 10.1016/j.bcmd.2007.06.023 · DOI
- Zhang, 2005, Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells, J Biol Chem., 280, 33885, 10.1074/jbc.M506207200 · DOI
- Nicolas, 2002, Hepcidin, a new iron regulatory peptide, Blood Cells Mol Dis., 29, 327, 10.1006/bcmd.2002.0573 · DOI · Paper page
- Pinto, 2008, Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha, Blood, 111, 5727, 10.1182/blood-2007-08-106195 · DOI · Paper page
- Vokurka, 2006, Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis, Physiol Res., 55, 667, 10.33549/physiolres.930841 · DOI · Paper page
- Tanno, 2009, Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells, Blood, 114, 181, 10.1182/blood-2008-12-195503 · DOI · Paper page
- Oelgeschläger, 2000, The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling, Nature, 405, 757, 10.1038/35015500 · DOI · Paper page
- Ross, 2001, Twisted gastrulation is a conserved extracellular BMP antagonist, Nature, 410, 479, 10.1038/35068578 · DOI · Paper page
- Chang, 2001, Twisted gastrulation can function as a BMP antagonist, Nature, 410, 483, 10.1038/35068583 · DOI · Paper page
- Xu, 2006, GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation, Circ Res., 98, 342, 10.1161/01.RES.0000202804.84885.d0 · DOI · Paper page
- Eling, 2006, NSAID activated gene (NAG-1), a modulator of tumorigenesis, J Biochem Mol Biol., 39, 649
- Braliou, 2008, 2-Oxoglutarate-dependent oxygenases control hepcidin gene expression, J Hepatol., 48, 801, 10.1016/j.jhep.2007.12.021 · DOI
- Tacchini, 1999, Transferrin receptor induction by hypoxia, J Biol Chem., 274, 24142, 10.1074/jbc.274.34.24142 · DOI · Paper page
- Mole, 2010, Iron homeostasis and its interaction with prolyl hydroxylases, Antioxid Redox Signal, 12, 445, 10.1089/ars.2009.2790 · DOI
- Shah, 2009, Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency, Cell Metab., 9, 152, 10.1016/j.cmet.2008.12.012 · DOI · Paper page
- Du, 2008, The serine protease TMPRSS6 is required to sense iron deficiency, Science, 320, 1088, 10.1126/science.1157121 · DOI · Paper page
- Finberg, 2008, Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA), Nat Genet., 40, 569, 10.1038/ng.130 · DOI · Paper page
- Folgueras, 2008, Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis, Blood, 112, 2539, 10.1182/blood-2008-04-149773 · DOI · Paper page
- Velasco, 2002, Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins, J Biol Chem., 277, 37637, 10.1074/jbc.M203007200 · DOI · Paper page
- Truksa, 2009, Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6, Br J Haematol., 147, 571, 10.1111/j.1365-2141.2009.07873.x · DOI
- Kemna, 2007, Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications, Clin Chem., 53, 620, 10.1373/clinchem.2006.079186 · DOI · Paper page
- Schranz, 2009, Activation and inactivation of the iron hormone hepcidin: biochemical characterization of prohepcidin cleavage and sequential degradation to N-terminally truncated hepcidin isoforms, Blood Cells Mol Dis., 43, 169, 10.1016/j.bcmd.2009.03.008 · DOI
- Gagliardo, 2009, Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process, J Hepatol., 50, 394, 10.1016/j.jhep.2008.09.018 · DOI
- Swinkels, 2008, Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry, PLoS One, 3, e2706, 10.1371/journal.pone.0002706 · DOI · Paper page
- Peslova, 2009, Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood, Blood, 113, 6225, 10.1182/blood-2009-01-201590 · DOI
- Roe, 2007, Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women, Br J Nutr., 97, 544, 10.1017/S0007114507336829 · DOI
- Kemna, 2005, Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS, Blood, 106, 1864, 10.1182/blood-2005-03-1159 · DOI · Paper page
- Tomosugi, 2006, Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System, Blood, 108, 1381, 10.1182/blood-2005-10-4043 · DOI · Paper page
- Kemna, 2005, Novel urine hepcidin assay by mass spectrometry, Blood, 106, 3268, 10.1182/blood-2005-05-1873 · DOI
- Murphy, 2007, Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry, Blood, 110, 1048, 10.1182/blood-2006-11-057471 · DOI · Paper page
- Murao, 2007, Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up, Rapid Commun Mass Spectrom., 21, 4033, 10.1002/rcm.3319 · DOI
- Kobold, 2008, Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry, Clin Chem., 54, 1584, 10.1373/clinchem.2008.107029 · DOI
- De Domenico, 2008, The hepcidin-binding site on ferroportin is evolutionarily conserved, Cell Metab., 8, 146, 10.1016/j.cmet.2008.07.002 · DOI
- Grebenchtchikov, 2009, High-sensitive radioimmunoassay for human serum hepcidin, Br J Haematol., 146, 317, 10.1111/j.1365-2141.2009.07758.x · DOI
- Koliaraki, 2009, A novel immunological assay for hepcidin quantification in human serum, PLoS One, 4, e4581, 10.1371/journal.pone.0004581 · DOI
- Kroot, 2009, Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization, Haematologica, 94, 1748, 10.3324/haematol.2009.010322 · DOI · Paper page
- Weiss, 2009, Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy, Eur J Clin Invest., 39, 883, 10.1111/j.1365-2362.2009.02182.x · DOI
- Peters, 2009, Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate, Nephrol Dial Transplant.
- Kato, 2008, Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients, Am J Nephrol., 28, 115, 10.1159/000109968 · DOI
- Swinkels, 2008, Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?, Nephrol Dial Transplant., 23, 2450, 10.1093/ndt/gfn267 · DOI
Cited by
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Babitt, J. L., & Lin, H. Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111078 · Cited by 1,041
Self-citationInterleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Update on Inflammation in Chronic Kidney Disease
Akchurin, O. M., & Kaskel, F. (2015) · Blood Purification · doi:10.1159/000368940 · Cited by 603
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
David, V., Martin, A., Isakova, T., Spaulding, C., Qi, L., Ramirez, V., Zumbrennen-Bullough, K. B., Sun, C. C., Lin, H. Y., Babitt, J. L., et al. (2016) · Kidney International · doi:10.1038/ki.2015.290 · Cited by 494
Self-citation
Metadata
- Authors
- Babitt, J. L., & Lin, H. Y.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 55
- Issue
- 4
- Pages
- 726-741
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2095421717
- Cited by
- 235
- References
- 61
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD. https://app.cochat.ai/papers/10.1053/j.ajkd.2009.12.030
- The paper
- Babitt, J. L., & Lin, H. Y. (2010). Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2009.12.030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.